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Abstract
Oxidative stress is implicated in the pathogenesis of neurodegenerative disorders and hydrogen peroxide (H2O2) plays a
central role in the stress. Huprines, a group of potent acetylcholinesterase inhibitors (AChEIs), have shown a broad
cholinergic pharmacological profile. Recently, it has been observed that huprine X (HX) improves cognition in non
transgenic middle aged mice and shows a neuroprotective activity (increased synaptophysin expression) in 3xTg-AD mice.
Consequently, in the present experiments the potential neuroprotective effect of huprines (HX, HY, HZ) has been analyzed
in two different in vitro conditions: undifferentiated and NGF-differentiated PC12 cells. Cells were subjected to oxidative
insult (H2O2, 200 mM) and the protective effects of HX, HY and HZ (0.01 mM–1 mM) were analyzed after a pre-incubation
period of 24 and 48 hours. All huprines showed protective effects in both undifferentiated and NGF-differentiated cells,
however only in differentiated cells the effect was dependent on cholinergic receptors as atropine (muscarinic antagonist,
0.1 mM) and mecamylamine (nicotinic antagonist, 100 mM) reverted the neuroprotection action of huprines. The decrease in
SOD activity observed after oxidative insult was overcome in the presence of huprines and this effect was not mediated by
muscarinic or nicotinic receptors. In conclusion, huprines displayed neuroprotective properties as previously observed in in
vivo studies. In addition, these effects were mediated by cholinergic receptors only in differentiated cells. However, a non-
cholinergic mechanism, probably through an increase in SOD activity, seems to be also involved in the neuroprotective
effects of huprines.
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Introduction
Alzheimer’s disease (AD) is the most common neurodegener-
ative disorder and the most prevalent cause of dementia with
ageing. The presence of b-amyloid (Ab)-containing senile plaques
and neurofibrillary tangles in the AD brain are the main hallmarks
of the disease and are widely believed to be responsible for
neuronal degeneration and cell death in this disorder [1].
Although the AD aetiology and pathogenesis are still unknown,
several reports point out that excitotoxicity, reduced energy
metabolism, mitochondrial dysfunctions, and oxidative stress are
very important mechanisms involved in cell death in AD [2]. This
hypothesis is supported by the finding that Ab peptides are
associated with free-radical oxidative stress and are the main cause
of cellular dysfunctions [3],[4],[5],[6],[7]. As a consequence of
that, necrotic and apoptotic processes occur and are the main
pathways of cell death in AD [8],[9],[10],[11].
The key symptoms of AD are primarily caused by choliner-
gic dysfunction, and a significant correlation has been found
between a cortical decrease in cholinergic activity and cog-
nitive deterioration (the cholinergic hypothesis). The present
approved therapeutic approach is mainly based on increasing
cholinergic transmission using cholinesterase inhibitors (ChEI)
[12],[13],[14],[15],[16],[17]. However, the therapeutic benefit of
such agents is not entirely explained by increasing activity of the
cholinergic system, and a large body of evidence shows that ChEI
have multiple effects on the central nervous system, some of which
could be regarded as broadly neuroprotective [13],[18],[19].
Thus, donepezil, the most widely prescribed AD therapy,
markedly decreases lactate dehydrogenase (LDH) release in
cortical cells previously exposed to oxygen-glucose deprivation
(OGD), and in addition it has a protective effect in gerbils [19].
Similar results have been observed in cell cultures in which
neurotoxicity was induced using Ab protein [20]. It has been
suggested that the efficacy of galantamine, a modest AChEI, with
allosteric modulator activity on the nicotinic receptor, can be
ascribed to its neuroprotective activity mediated by a7 nicotinic
receptors [18]. Rivastigmine, another AChEI recently approved,
also has a neuroprotective effect although it is completely
independent of nicotinic receptors [21]. Consequently, AChEI
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e74344
might be able to act as disease-modifying anti-Alzheimer drugs
rather than as mere palliative drugs [22].
It has been demonstrated that huprines, a group of antic-
holinesterasic drugs obtained by the molecular hybridization of
tacrine and (6)-huperzine A, show high selectivity and a potent
inhibitory action on AChE in both in vitro and ex vivo studies
[23],[24], an agonistic action on muscarinic and nicotinic
receptors [25],[26], and can affect the binding of ligands to the
peripheral site of AChE, thereby inhibiting the amyloidogenic
process induced by the enzyme [27],[28]. Despite controversial
data about the ability of tacrine to exhibit a neuroprotective effect
[21],[29], it has been widely demonstrated that huperzine A, the
other component of the huprine molecule, shows a neuroprotec-
tive activity against different stimuli in several experimental
conditions [29],[30]. Interestingly, a recent in vivo study has
revealed the neuroprotective effect of huprine X, since in 3xTg
mice treated with the drug, it significantly increased the
synaptophysin content to levels close to those of non-transgenic
mice [31] and improved cognition by regulating some neuro-
chemical processes, such as alpha secretases and glycogen synthase
kinase 3-beta, in the same transgenic mice [32].
Clonal cell-lines, such as rat pheochromocytoma PC12 cells,
provide a useful model system for the investigation of neuronal
injury. In contrast with central nervous system primary cultures,
which contain many types of nerve cells as well as glial populations,
clonal nerve cell-lines yield homogeneous populations, allow an
easy manipulation and control over the extracellular milieu, and
provide definite advantages over animal experiments. Due to the
multitarget pharmacological profile of huprines and because of the
importance of oxidative stress in most neurodegenerative diseases,
especially in AD, in the present study the potential neuroprotective
effects of huprine X (12-amino-3-chloro-9-ethyl-6,7,10,11-tetrahy-
dro-7,11-methanocycloocta[b]quinoline hydrochloride), huprine Y
(12-amino-3-chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methano-
cycloocta[b]quinoline hydrochloride) and huprine Z (12-amino-
3-fluoro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]-
quinoline hydrochloride) were assessed. For this purpose,
undifferentiated and differentiated PC12 cells were subjected
to a necrotic insult (hydrogen peroxide), this being the most
common process in all degenerative disorders [11],[33].
Results
Effect of huprines on cell death induced by H2O2 in PC12
cells
1. Undifferentiated PC12 cells. Firstly, the cells were
incubated in the presence of HX, HY, and HZ (1 mM, 0.1 mM,
0.01 mM) during 1 h and 2 h prior to H2O2 addition. In these
experimental conditions no protective effects were found (data not
shown). In the light of these data, we proceeded to increase the
incubation time of drugs to 24 h and 48 h prior to H2O2 addition.
The effect of H2O2 treatment and of the pre-treatment with
huprines prior to H2O2 addition in cell survival is shown in Fig. 1.
In the 24 h pre-treatment of huprines prior to H2O2 addition,
drugs induced a percentage of protection between 47% and 65%
at 1 mM and 0.1 mM but no significant changes were observed at
0.01 mM (Table 1). When the pre-treatment period was increased
to 48 h, a significant increase in the protection percentage was
observed at all concentrations used, even at 0.01 mM (between
12% and 70%).
In no case modifications in cell survival were observed when
huprines were incubated alone (without H2O2) at concentrations
of 0.01 mM, 0.1 mM, and 1 mM, nevertheless, at concentrations as
Figure 1. Attenuation of H2O2-induced cell damage by
different concentrations (0.01 mM, 0.1 mM, 1 mM) of (A) HX,
(B) HY and (C) HZ in undifferentiated PC12 cells. Cells were
incubated with 200 mM H2O2 for 2 h. Huprines were added to the
culture 24–48 h prior to H2O2 addition. Cell viability was assessed by
PC12 Cells Protected by Huprines Against H2O2
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high as 10 mM and 100 mM, huprines reduced cellular viability
(data not shown).
2. NGF differentiated PC12 cells. Similar to undifferenti-
ated PC12 cells, nerve growth factor (NGF)-treated PC12 cells
suffered around a 50% reduction of cellular viability when they
were exposed to the H2O2 insult (200 mM) for 2 h. Taking the
results obtained with undifferentiated PC12 cells as starting point,
in this set of experiments drugs were pre-incubated for 48 h and
HX, HY, and HZ were added at concentrations of 0.1 mM and
1 mM (Fig. 2). In this experimental approach a percentage of
protection ranging from 44% to 56% was obtained with all of the
huprines at both concentrations used (Table 2).
Role of muscarinic and nicotinic receptors in the
neuroprotective effects of huprines
1. Undifferentiated PC12 cells. Because previous studies in
our laboratory have shown that huprines interact with muscarinic
and nicotinic receptors [26],[34],[35], we studied the possible role
of cholinergic receptors in the neuroprotective effect exerted by
huprines. For this purpose, MEC (100 mM), a nicotinic receptor
(nAChR) antagonist, or ATR (0.1 mM), a muscarinic receptor
antagonist, were used. Each antagonist was added to the medium
concomitantly with huprines. Neither MEC nor ATR antagonised
the increase of the survival induced by 48 h of pre-treatment with
huprines in undifferentiated PC12 cells (Table 1). These results
suggest that the neuroprotective effect of huprines in this cell line is
not mediated by an interaction with muscarinic or nicotinic
receptors.
Worthy of note, addition of MEC and ATR alone did not
modify cell viability.
2. NGF-differentiated PC12 cells. The role of muscarinic
and nicotinic receptors in NGF-differentiated PC12 cells was also
assessed. In this case, MEC (100 mM) significantly prevented the
protective effect of huprines, reducing significantly the neuropro-
tection percentage induced by drugs (Table 2). ATR (0.1 mM) also
significantly reduced the neuroprotection effects of huprines,
however this reduction was lower than that observed in the
presence of MEC.
Effect of huprines on SOD activity
1. Undifferentiated PC12 cells. PC12 cultures exposure to
H2O2 (200 mM) for 2 h produced a marked decrease of superoxide
dismutase (SOD) activity, as compared with control cells. The
48 h pre-treatment of the undifferentiated PC12 cells with HX,
HY, and HZ (0.01 mM–1 mM) prior to H2O2 addition led to a
significant increase (24%–86%) of SOD activity, when compared
with the H2O2-treated group (Fig. 3). The levels of SOD activity
after the huprines (0.1 mM–1 mM) treatment could also surpass the
SOD activity levels of the control cells. This increase in SOD
activity might be related to the neuroprotective effect of the
huprines against H2O2.
Incubation of huprines in the absence of H2O2 did not modify
the enzyme activity.
2. NGF-differentiated PC12 cells. The 2 h exposure to
H2O2 (200 mM) led to a remarkable reduction in SOD activity,
while pre-treatment with huprines prior to H2O2 addition
significantly increased the enzymatic activity. This modification
was found in all of the huprines at the concentration of 1 mM
(Fig. 4). Given that cell viability is greatly reduced in the presence
of MEC in NGF-treated PC12 cells, and the fact that nAChRs
have been involved in SOD activation [36], the role of such
receptors in the SOD activity was assessed. MEC slightly reversed
the enzyme activity, but this reversion was not statistically
measuring the MTT reduction. At least three independent experiments
were carried out in triplicate. The data are means 6 s.e.m. expressed as
percentage of control value. *P,0.05 compared with H2O2 group
(Dunnett’s test).
doi:10.1371/journal.pone.0074344.g001
Table 1. Effect of huprines pretreatment on undifferentiated PC12 cell survival after exposure of cells to H2O2 (200 mM).
TREATMENT % PROTECTION 24 H % PROTECTION 48 H
Huprine X (1 mM) 4760.6* 7064.8*
Huprine X (0.1 mM) 4962.9* 7464.6*
Huprine X (0.01 mM) 360.9 1265.4*
Huprine X (1 mM) +MEC (100 mM) 6860.5a
Huprine X (1 mM) +ATR (0.1 mM) 66610.2a
Huprine Y (1 mM) 5262.3* 6063.6*
Huprine Y (0.1 mM) 4768.7* 5163.3*
Huprine Y (0.01 mM) 465.5 2265.5*
Huprine Y (1 mM) +MEC (100 mM) 6169.3b
Huprine Y (1 mM) +ATR (0.1 mM) 5861.2b
Huprine Z (1 mM) 6262.2* 6560.5*
Huprine Z (0.1 mM) 6561.3* 6560.5*
Huprine Z (0.01 mM) 0.562.4 2763.7*
Huprine Z (1 mM) +MEC (100 mM) 5964.7c
Huprine Z (1 mM) +ATR (0.1 mM) 5567.6c
Effect of antagonists mecamylamine (MEC) and atropine (ATR) on huprines protective effect on PC12 cells survival after exposure of the cells to H2O2. See Methods for
details of cell treatment and conditions. Values are expressed as percentage of protection (mean 6 s.e.m.) obtained from at least three independent experiments run in
triplicate. *P,0.05 as compared with H2O2–treated group (Dunnett’s test).
a,b,c No significant changes compared with huprine X, Y and Z (1 mM), respectively.
doi:10.1371/journal.pone.0074344.t001
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significant (Fig. 4). ATR did not modify the increase of SOD
induced by drugs (data not shown).
Discussion
Besides the pathological hallmarks of AD, which include the
accumulation of protein deposits in the brain as Ab plaques and
neurofibrillary tangles (NFT), AD brains exhibit constant evidence
of reactive oxygen species (ROS) - and reactive nitrogen species
(RNS)-mediated injury [37]. In some circumstances the produc-
tion of oxidant species can exceed the endogenous antioxidant
ability to destroy them, and an oxidative imbalance occurs.
Consequently, the protection of neurons from oxidative damage
and death is an important challenge in the development of new
treatments against neurodegenerative diseases. PC12 is a cell line
characterised by showing sympathetic neuronal cell properties,
morphologically, physiologically, and biochemically [38]. In
addition, when they are incubated with NGF, PC12 cells increase
the expression of cholinergic receptors, choline acetyltransferase
expression and acetylcholinesterase activity [39]. Therefore, PC12
cells represent an appropriate experimental approach to study the
role of cholinergic receptors in the neuroprotective effect of
acetylcholinesterase inhibitors under different conditions.
First of all, we subjected the undifferentiated PC12 cells to an
oxidative insult, such as hydrogen peroxide, not only because it is a
hydrogen free-radical generator, but also because the toxicity of
Ab, the major pathological hallmark for AD, is partially mediated
by hydrogen peroxide [40]. Using this experimental approach, the
present results have revealed that HX, HY, and HZ induced a
significant protective effect against hydrogen peroxide. All
huprines showed a similar effect, suggesting that the slight
structural differences among the three compounds are not relevant
for their protective activity.
Neuroprotection is a very common feature among different
AChEIs in response to different harmful insults. Thus, the
acetylcholinesterase inhibitor galantamine showed a protective
effect after Ab or thapsigargin stimulus in the human neuroblas-
toma cell line SH-SY5Y, as well as in bovine chromaffin cells [41].
Additionally, donepezil, rivastigmine and galantamine showed a
neuroprotective effect against okadaic acid in undifferentiated SH-
SY5Y cells [21]. Huperzine A, one of the parent compounds from
which huprines were designed, showed a protective effect after
inducing oxygen-glucose deprivation in pheochromocytoma cells,
most likely by alleviating disturbances of oxidative and energy
metabolism [42] or in the presence of hydrogen peroxide, which
improved expression of apoptosis-related genes [43]. Nevertheless,
it is necessary to state that the protective effect of huprines was
only apparent when cells were preincubated with the drugs for
periods of 24 h or longer (48 h), suggesting that a prolonged
treatment before hydrogen peroxide exposure is necessary to elicit
Figure 2. Atenuation of H2O2-induced cell damage by 0.1 mM and 1 mM concentrations of huprines: HX, HY and HZ in NGF
differenciated PC12 cells. Cells were incubated with 200 mM H2O2 for 2 h. Compounds were added to the culture 48 h prior to H2O2 addition. Cell
viability was assessed by measuring the MTT reduction. At least three independent experiments were carried out in triplicate. The data are means 6
s.e.m. expressed as percentage of control value. *P,0.05 compared with H2O2 group (Dunnett’s test).
doi:10.1371/journal.pone.0074344.g002
Table 2. Effect of huprines pretreatment on NGF
differentiated PC12 cells survival after exposure of cells to
H2O2 (200 mM).
TREATMENT % PROTECTION 48 H
Huprine X (1 mM) 5365.0*
Huprine X (0.1 mM) 4466.0*
Huprine X (1 mM) +MEC (100 mM) 763.2b
Huprine X (1 mM) +ATR (0.1 mM) 3262.7b
Huprine Y (1 mM) 5665.0*
Huprine Y (0.1 mM) 4966.1*
Huprine Y (1 mM) +MEC (100 mM) 2.360.9b
Huprine Y (1 mM) +ATR (0.1 mM) 1661.6b
Huprine Z (1 mM) 5667.0*
Huprine Z (0.1 mM) 4767.5*
Huprine Z (1 mM) +MEC (100 mM) 1763.4b
Huprine Z (1 mM) +ATR (0.1 mM) 2767.1b
Effect of antagonists mecamylamine (MEC) and atropine (ATR) on huprines
protective effect on PC12 cells survival after exposure of the cells to H2O2. See
Methods for details of cell treatment and conditions. Values are expressed as
percentage of protection (mean 6 s.e.m.) obtained from at least three
independent experiments run in triplicate. *P,0.05 as compared with H2O2–
treated group; bP,0.05 as compared with 1 mM concentration of
corresponding drug (Dunnett’s test).
doi:10.1371/journal.pone.0074344.t002
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their neuroprotective activity. Indeed, when drugs were added
concomitantly with hydrogen peroxide or even a few hours before
inducing the insult, no protective effects of huprines were observed
(data not shown). The relevance of the incubation time prior to the
addition of some toxic agents is well established in the literature.
Studies performed with donepezil, galantamine, and tacrine in
cortical neurons using glutamate as a toxic agent have shown that
the protective effects of these drugs were more pronounced at
longer incubation periods [44],[45]. It has been suggested that a
delay in the neuroprotective effects of some AChEIs could be
ascribed to the cascade of events that take place after nicotinic
receptor activation [44]. Herein, the neuroprotective effects of
huprines were higher when the preincubation time was extended
up to 48 h, and in these conditions the effects of the drugs were
also observed at a concentration as low as 10 nM. These data
could also suggest that the effects of huprines are less apparent
when the cell damage has been already established. In fact, HX
improved cognitive deficits in 3xTg-AD mice 7 months old [41]
but such effect was not observed in 12 month old 3xTg-AD mice
(non published data).
In addition to their high affinity inhibition of AChE (picomolar
range) these compounds are able to stimulate muscarinic and
nicotinic receptors [25],[34],[46]. These data led us to speculate
that the agonistic effect of the huprines on cholinergic receptors
could trigger the neuroprotective effect together with the
potentiation of the cholinergic system associated with the
inhibitory effect on AChE. In fact, the neuroprotective effect
observed in some AChEIs has been ascribed to their activity on
Figure 3. Modulation of the SOD activity in undifferentiated PC12 cells after preincubation with HX, HY and HZ. Cells were incubated
with 200 mM H2O2 for 2 h. Huprines were added to the culture 48 h prior to H2O2 addition. SOD activity was measured with a SOD activity assay from
Fluka. At least three independent experiments were carried out in triplicate. The data are means 6 s.e.m. expressed as percentage of control value.
*P,0.05 compared with H2O2 group (Dunnett’s test).
doi:10.1371/journal.pone.0074344.g003
Figure 4. Modulation of the SOD activity in NGF-PC12 differenciated cells by HX, HY and HZ. Huprines were added alone or
concomitantly with MEC (100 mM) to the culture 48 h prior to H2O2 addition. Then, cells were incubated with 200 mM H2O2 for 2 h. SOD activity was
measured using a SOD activity assay from Fluka. At least three independent experiments were carried out in triplicate. The data are means 6 s.e.m.
expressed as percentage of control value. *p,0.05 compared with H2O2 group (Dunnett’s test).
doi:10.1371/journal.pone.0074344.g004
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nicotinic receptors [18]. In order to analyse the possible
involvement of cholinergic receptors in the protection induced
by huprines, MEC and ATR were used to block nicotinic and
muscarinic receptors, respectively. Both antagonists failed to
reverse the effect of all compounds in undifferentiated cells,
suggesting that the protection induced by huprines was not related
to their activity on cholinergic receptors. The latency period
between the addition of drugs to the incubation medium and
detection of the protective effect seems to indicate that the
mechanism of these drugs might include a chain of events inducing
the activation/inactivation of different factors.
Hydrogen peroxide is a free-radical generator that induces cell
and tissue damage. SOD is an antioxidant enzyme that plays a
pivotal role in maintaining a very low, steady state of intracellular
O2
- [47]. The activity of this enzyme was significantly increased by
huprines in undifferentiated cells, suggesting that changes in SOD
expression and/or activity might be involved in the protective
effects of huprines.
It is known that exposure of PC12 cells to NGF leads to changes
in their properties, increasing the cholinergic receptors expression.
In a second set of experiments we subjected PC12 cells to the
presence of NGF and once they were differentiated, cells were
treated for 48 h with huprines. As it was observed in undifferen-
tiated cells, HX, HY, and HZ elicited a significant protective effect
after adding hydrogen peroxide to the culture medium; however
the percentage of protection was lower than in the case of
undifferentiated cells. Differentiated cells seem to be more sensitive
to oxidant stimulus than undifferentiated cells [48], however, in
the present study all cells showed a similar sensitivity to hydrogen
peroxide. Huprines were not able to restore cell viability with the
same efficacy than in undifferentiated cells.
As mentioned above, NGF-differentiated PC12 cells increase
the presence of cholinergic factors, especially nicotinic and
muscarinic receptors, therefore cells were incubated with huprines
and concomitantly with MEC or ATR to block nicotinic and
muscarinic receptors, respectively. In contrast to that observed in
undifferentiated cells, in NGF-differentiated PC12 cells a signif-
icant reduction of the neuroprotective effects of huprines was
observed when the antagonists were added, achieving survival
values similar to those obtained in non-treated cells, especially in
the presence of MEC. ATR only induced a partial, but significant
reversion, of the protective effects of huprines. The role of
nicotinic receptors in neuroprotection has been widely described.
The higher transcription of nAChR, and especially the a5, a7, and
b4 subunits of the nAChR in NGF-differentiated cells [49], might
explain the differences obtained in undifferentiated and NGF-
differentiated PC12 cells. It has also been shown that the
neuroprotective effect of donepezil and galantamine against
glutamate could be reverted by a7 and b4 nAChR antagonists
and by some inhibitors of the IP3-kinases pathway [50]. This
complex pathway implies changes in a large number of proteins
involved in cellular proliferation and/or apoptosis, modifying the
balance between these two processes. Our data suggest that the
protection induced by huprines could be mainly related to the
nAChRs in NGF-differentiated cells. The higher reduction of the
neuroprotective effects of the huprines in the presence of the
nicotinic antagonist, as compared with the muscarinic antagonist,
is in consonance with the results obtained in other studies, which
highlight the role of nAChR in AD development [44],[50].
However, muscarinic receptors have also been related to
neuroprotection [51],[52]. Thus, activation of muscarinic recep-
tors could increase the antiapoptotic protein Bcl2 via MAPK, thus
preserving the viability of mouse cerebellar granule cells [53].
Herein, the effects of huprines on cell viability were also partially
mediated by muscarinic receptors in NGF-differentiated cells.
Finally, the activity of SOD in NGF-differentiated cells was also
analysed. As in the case of undifferentiated PC12 cells, a decrease
of SOD activity was induced by hydrogen peroxide. Again, the
presence of huprines promoted the recovery of enzyme activity. In
vivo administration of galantamine, an AChEI with nicotinic
activity, provides neuroprotection to gerbils in an ischaemia model
increasing, among others, SOD activity, and this effect was
inhibited by MEC [36]. Rivastigmine and also huperzine A and
huperzine B increase SOD activity [54],[55],[56], however, none
of these drugs has affinity to nAChRs. It has been demonstrated
that nAChRs modulate SOD activity by the activation of PI3K/
Akt, nevertheless, the same authors have highlighted the complex
regulation of this enzyme, suggesting that multiple positive and
negative regulatory elements can be involved [57]. In order to rule
out the role of nAChRs in the increase of SOD activity induced by
huprines, MEC was also tested in NGF-differentiated cells.
Antagonist MEC was unable to modify the effect of huprines on
SOD, suggesting that the increase of the enzyme activity induced
by huprines is not directly mediated by cholinergic receptors.
In summary, HX, HY, and HZ have shown neuroprotective
effects, thereby supporting previous data observed in in vivo studies
[31]. In addition, the subtle structural differences among huprines
seem to be not relevant for the neuroprotective effect, as all of
them provided similar neuroprotective activity. In addition, the
protection against hydrogen peroxide was independent of cholin-
ergic receptors in undifferentiated cells, whereas in NGF-
differentiated cells nAChRs seem to be involved in this effect, as
MEC was able to reverse the effects of huprines. Finally, huprines
increased SOD activity, which suggests the ability of the drugs to
decrease ROS accumulation in response to oxidative stress. The
fact that huprines induced their protective effect by different
mechanisms in differentiated cells, as compared to undifferentiated
ones, and that their action on SOD activity was totally
independent of nicotinic receptors, indicates that multiple
pathways can contribute to the protective activity of drugs, and
cellular mechanisms involved in such processes are also dependent
on the cellular system and environmental conditions in which they
are studied. These in vitro results could support in vivo data observed
in NTg and 3xT-AD mice treated by HX in which an
improvement in cognition and a positive regulation of synapto-
physin have been described [31],[32]. Consequently, more
experiments must be carried out to shed more light on the
molecular mechanisms involved in the neuroprotective effect of
huprines.
Material and Methods
Materials
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), dimethyl sulfoxide (DMSO), EDTA, foetal bovine serum,
glutamine, HEPES, horse serum, hydrogen peroxide, nerve
growth factor b (NGF-b), penicillin, poli-L-lysine hydrobromide,
potassium chloride, potassium phosphate monobasic, protease
inhibitor cocktail, RPMI-1640, sodium chloride, sodium phos-
phate dibasic dihydrate, sodium pyruvate, and streptomycin were
purchased from Sigma-Aldrich (St. Louis, USA). Glucose was
purchased from Merck (Darmstadt, Germany) and the enzyme
tripsine-0.2 g EDTA from Sigma-Aldrich (Saint Louis, USA).
Huprines X, Y, and Z (HX, HY and HZ) were synthesized at the
Laboratori de Quı´mica Farmace`utica, Facultat de Farma`cia,
Universitat de Barcelona. The antagonists atropine (ATR) and
mecamylamine (MEC) hydrochloride were obtained from Sigma-
PC12 Cells Protected by Huprines Against H2O2
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Aldrich (St. Louis, USA). Superoxide dismutase activity was
determined using the SOD assay kit from Fluka, Sigma-Aldrich,
and the Bradford protein assay from Bio-rad (Hercules, California,
USA) was used to quantify proteins.
Cell culture and treatment
The rat pheochromocytoma cell line PC12 is a classic in vitro
neuroendocrine cell model. Unlike primary neurons, undifferen-
tiated PC12 cells do not require NGF for survival, but they
respond to it by producing lengthy neurite extensions and by
undergoing other neural-specific changes such as an increase of
cholinergic receptors expression [58],[59]. NGF-treated PC12
cells exhibit many of the hallmarks of differentiated neurons.
PC12 cells (ATCC, CRL-1721) were generously provided by
Dr. N. Gomez (Biochemistry and Molecular Biology Department,
UAB, Barcelona, Spain) and grown on polystyrene tissue-culture
dishes in RPMI-1640 containing 10% horse serum and 5% foetal
bovine serum, supplemented with 2 mM glutamine, 1 mM
pyruvate, 100 unit/mL penicillin and 100 mg/mL streptomycin
at 37uC with 95% air25% CO2. All experiments were carried out
24 h after cells were seeded in 24-well or 6-well plates previously
treated with poly-L-lysine hydrobromide. The cellular density in 6-
well plates was 200,000 cells/mL and in 24-well plates about
30,000 cells/mL. For experiments in undifferentiated cells 24-well
plates were used and the drug treatments were directly started
24 h after seeding the cells. For cell differentiation, the 6-well
plates were used and cells were treated with NGF-b 100 ng/mL
for 7 days prior to huprines addition. To induce necrosis, cells
were incubated with the indicated concentration of H2O2 for 2 h.
To study the effects of huprines on PC12 cells, cells were
preincubated with different concentrations of drugs for 24 h or
48 h before addition H2O2. When antagonists mecamylamine
(MEC, nicotinic receptor antagonist) and atropine (ATR, musca-
rinic receptor antagonist) were used they were added concomi-
tantly with agonists.
Cell viability assay
Cell viability was measured by the method of MTT described
by Mosmann [60]. Briefly, cells in 24-well plates were rinsed with
phosphate-buffered saline (PBS), MTT (0.5 mg/mL) was added to
each well and incubated for 30 min at 37uC. After removal of the
medium with MTT, cells and dye crystals were solubilised with
200 mL DMSO, and optical density was measured at 570 nm on a
microplate reader. The percentage of protection was calculated
according to the following equation:
%Protection~
½survival(drugzH2O2){survival(H2O2)x100
survival(control){survival(H2O2)
Enzymatic assay
For the assay of SOD activity, the cultures were washed with
ice-cold PBS and then pooled in 0.1 M PBS, 0.05 mM EDTA
buffered solution and homogenized. The homogenate was
centrifuged for 1 h at 10,000xg. The resulting supernatants were
used in this assay. Superoxide dismutase activity was determined
using the SOD assay Kit-WST, obtained from Fluka and was
measured in accordance with the instructions supplied by the
manufacturer. Briefly, samples were incubated at 37uC for 20 min
and the SOD activity, as an inhibition activity, was quantified by
measuring the decrease in the color development (amount of
superoxide anion) at 440 nm. The effect of huprines on SOD
activity was evaluated as the percentage of control group values.
The protein level in cells was measured by Bradford method, using
bovine serum albumin as standard [61].
Statistical analysis
Data are expressed as means 6 SEM and evaluated for
statistical significance (P,0.05) with one-way ANOVA followed
by Duncan’s multiple-range test.
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